Position in DGX
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$3,827,393
+$615,869 QoQ
Shares Held
18,058
+10.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#282
of 1,090 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rakuten Investment Management, Inc. holds $82,930,368 across 8 Diagnostics & Research names. DGX ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
60,839 | $30,502,241 | |
| 2 | DHR |
Danaher Corp /De/
|
103,733 | $19,759,061 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
19,036 | $10,021,311 | |
| 4 | A |
Agilent Technologies, Inc.
|
46,470 | $6,172,610 | |
| 5 | WAT |
Waters Corp /De/
|
16,068 | $6,026,142 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
27,459 | $5,305,627 | |
| 7 | DGX |
Quest Diagnostics Inc
This page
|
18,058 | $3,827,393 | |
| 8 | RVTY |
Revvity, Inc.
|
11,828 | $1,315,983 |
All Filings in DGX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,827,393 | 18,058 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $3,211,524 | 16,387 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,543,602 | 14,658 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,713,043 | 24,730 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $1,719,579 | 10,163 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $978,540 | 6,303 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $646,758 | 4,725 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $398,930 | 2,997 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $38,330 | 278 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||